GlassScriptPhysician profile
Jared Weinand
NPI 1205497815
$3,118.62
in general payments reported to CMS, 2019-2025
10 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $225 · 2024: $2,622 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $2,216 · Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $2,216.21 |
| Food and Beverage | $902.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,244.17 | 2024-2025 | Kyphon Express II Kyphopak Tray |
| Okami Medical, INC. | $205.16 | 2024 | Lobo |
| Sirtex Medical INC | $149.35 | 2024 | Sir-Spheres Microspheres |
| Bard Peripheral Vascular, INC. | $147.44 | 2025 | Covera |
| W. L. Gore & Associates, INC. | $128.56 | 2023 | Viatorr Endoprosthesis |
| Boston Scientific Corporation | $96.09 | 2023 | Obsidio |
| Terumo Medical Corporation | $50.92 | 2024 | Angio-Seal, Azur Cx Detachable, Glidewire |
| Reflow Medical INC | $35.13 | 2025 | |
| Abbott Laboratories | $34.57 | 2025 | Esprit |
| Tactile Systems Technology INC | $27.23 | 2025 | Flexitouch Plus, Nimbl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Weinand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.